BRAF and cancer: The analysis revealed the enrichment of the KEGG pathway ‘MicroRNAs in cancer’ and the reactome pathways ‘Initiation of Nuclear Envelope (NE) Reformation’, ‘Signaling by BRAF and RAF fusions’, and ‘Diseases of signal transduction by growth factor receptors and second messengers’, with false discovery rates of 0.0396, 0.0353, 0.0094, and 0.0051, respectively.